REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,088.00
Bid: 12,086.00
Ask: 12,090.00
Change: 38.00 (0.32%)
Spread: 4.00 (0.033%)
Open: 11,966.00
High: 12,124.00
Low: 11,966.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-UK blue chips hit 9-month high on Brexit trade deal cheer

Tue, 29th Dec 2020 09:52

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Brexit deal sparks rally in UK stocks

* FTSE 100 at highest since March

* Hut Group rises on online retailer acquisition

* FTSE 100 up 1.6%, FTSE 250 adds 1.7%
(Updates to market close)

By Shivani Kumaresan

Dec 29 (Reuters) - Britain's blue-chip FTSE 100 index ended
at its highest since March on Tuesday as investors returned from
a long weekend to cheer a post-Brexit trade deal that averted a
chaotic exit from the European Union.

In its first day of trading after the deal, the blue-chip
FTSE 100 index gained 1.6%, logging its best day since
Nov. 9.

International companies such as Unilever and Diageo
gave the biggest boost to the FTSE 100 despite a firmer
pound, while drugmakers AstraZeneca and GlaxoSmithKline
also added to the gains.

"The deal should see sentiment towards the FTSE indices
recover just as the dividend payout ratio improves, vaccines are
rolled out and overseas revenues accelerate. We lift UK equities
to Bullish," analysts at brokerage Jefferies wrote in a note.

The coming days will provide a first taste of the effects of
Brexit and regulators on both sides of the English Channel will
be on alert for market dislocations on Jan. 4, the first trading
day of the new year.

"The honest answer is we do not know what January 1st will
hold. In all likelihood, there will be delays and bedding-in
period as the new reality and processes are explored and
enacted," said Jeffrey Halley, senior market analyst at OANDA.

The deal would ensure traded goods that make up half of
annual EU-UK commerce remain free of tariffs beyond Dec. 31.

The domestically-focussed FTSE 250 index climbed
1.7% to its highest level since Feb. 25.

The UK stock market has tracked a global rally this year
following the coronavirus-led crash in March, but lagged
European and U.S. peers on fears of a long road to pre-pandemic
levels of economic growth.

On individual stocks, shares in Hut Group rose 8.9%
after the e-commerce company said it would buy U.S. online
retailer Dermstore from Target Corp for $350 million in
cash.

British insurer Admiral gained 3.4% after reports
of Zoopla Property Group buying its Penguin Portals and Preminen
businesses.
(Reporting by Shivani Kumaresan in Bengaluru; Editing by
Subhranshu Sahu, Aditya Soni and Emelia Sithole-Matarise)

More News
Today 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.